“…For instance, H19 was the first lncRNA associated with cancer, which is upregulated in many types of human cancer, such as liver cancer, bladder cancer, and breast cancer, and functions as an oncogene [6,7]. Some tumor-related lncRNAs are also capable of serving as potential markers, and dysregulation of their expression is often related to the clinicopathological features and even prognosis of patients [8][9][10][11]. For example, MALAT-1 enhances the cell motility of lung adenocarcinoma and is treated as a specific marker of non-small cell lung cancer, especially in the early metastasis stage of lung adenocarcinoma [9].…”